Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an imaging-guided pathway replace the current paradigm for muscle-invasive bladder cancer?

Bryan, Richard T; Catto, James W F; Jefferson, Kieran P; Patel, Prashant; James, Nicholas D; On Behalf Of The BladderPath Trial Management Group

Name:

Publisher version

Author

Bryan, Richard T
Catto, James W F
Jefferson, Kieran P
Patel, Prashant
James, Nicholas D
On Behalf Of The BladderPath Trial Management Group

Affiliation

University of Birmingham; University of Sheffield; Sheffield Teaching Hospitals NHS Trust; University Hospital Coventry & Warwickshire; University Hospitals Birmingham NHS Foundation Trust; Institute of Cancer Research; The Royal Marsden NHS Foundation Trust

Publication date

2021-05-08

Subject

Urology
Oncology. Pathology.

Metadata

Show full item record

Abstract

No abstract available

Citation

Bryan RT, Catto JWF, Jefferson KP, Patel P, James ND, On Behalf Of The BladderPath Trial Management Group. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol. 2021 Jul;80(1):18-19. doi: 10.1016/j.eururo.2021.04.034. Epub 2021 May 8.

Type

Correspondence